S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:SYNHSyneos Health Stock Price, Forecast & News

$62.51
-0.25 (-0.40 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
$62.10
Now: $62.51
$63.40
50-Day Range
$54.26
MA: $59.88
$65.09
52-Week Range
$30.02
Now: $62.51
$74.25
Volume447,000 shs
Average Volume702,488 shs
Market Capitalization$6.52 billion
P/E Ratio35.12
Dividend YieldN/A
Beta1.8
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More
Syneos Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.08 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SYNH
CUSIPN/A
Phone919-876-9300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.68 billion
Cash Flow$5.10 per share
Book Value$29.19 per share

Profitability

Net Income$131.26 million

Miscellaneous

Employees24,000
Market Cap$6.52 billion
Next Earnings Date10/29/2020 (Estimated)
OptionableOptionable
$62.51
-0.25 (-0.40 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SYNH News and Ratings via Email

Sign-up to receive the latest news and ratings for SYNH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Syneos Health (NASDAQ:SYNH) Frequently Asked Questions

How has Syneos Health's stock price been impacted by Coronavirus (COVID-19)?

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SYNH stock has increased by 9.1% and is now trading at $62.51.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Syneos Health?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Syneos Health
.

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Syneos Health
.

How were Syneos Health's earnings last quarter?

Syneos Health Inc (NASDAQ:SYNH) posted its quarterly earnings results on Thursday, August, 6th. The company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.20. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. Syneos Health had a net margin of 4.10% and a return on equity of 9.63%. The company's quarterly revenue was down 13.1% on a year-over-year basis. During the same quarter last year, the company earned $0.74 earnings per share.
View Syneos Health's earnings history
.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health updated its FY20 earnings guidance on Thursday, August, 6th. The company provided EPS guidance of $3.16-3.38 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.00. The company issued revenue guidance of $4.47-4.57 billion, compared to the consensus revenue estimate of $4.45 billion.

What price target have analysts set for SYNH?

12 brokerages have issued 1 year price targets for Syneos Health's shares. Their forecasts range from $45.00 to $82.00. On average, they anticipate Syneos Health's stock price to reach $65.33 in the next year. This suggests a possible upside of 4.5% from the stock's current price.
View analysts' price targets for Syneos Health
.

Has Syneos Health been receiving favorable news coverage?

News stories about SYNH stock have trended very negative this week, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Syneos Health earned a news impact score of -3.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near term.
View the latest news about Syneos Health
.

Who are some of Syneos Health's key competitors?

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Icon (ICLR), Netflix (NFLX), Square (SQ), AT&T (T), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA) and JD.Com (JD).

Who are Syneos Health's key executives?

Syneos Health's management team includes the following people:
  • Mr. Alistair Macdonald, CEO & Director (Age 49)
  • Mr. Jason M. Meggs, Chief Financial Officer (Age 43)
  • Mr. Jonathan Olefson, Gen. Counsel & Corp. Sec. (Age 43)
  • Mr. Michael Adam Bell, Consultant (Age 63)
  • Mr. Robert Parks, Exec. VP & Chief Accounting Officer

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (1.34%), GW&K Investment Management LLC (1.34%), Goldman Sachs Group Inc. (0.81%), Principal Financial Group Inc. (0.70%), Thrivent Financial for Lutherans (0.69%) and Palisade Capital Management LLC NJ (0.58%). Company insiders that own Syneos Health stock include Alistair Macdonald, Jason M Meggs, John M Dineen, Jonathan Olefson, Michelle Keefe, Paul Colvin and Robert Parks.
View institutional ownership trends for Syneos Health
.

Which major investors are selling Syneos Health stock?

SYNH stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Victory Capital Management Inc., Prudential Financial Inc., Thrivent Financial for Lutherans, Barclays PLC, Mutual of America Capital Management LLC, Bank of New York Mellon Corp, and American International Group Inc.. Company insiders that have sold Syneos Health company stock in the last year include Alistair Macdonald, Michelle Keefe, and Robert Parks.
View insider buying and selling activity for Syneos Health
.

Which major investors are buying Syneos Health stock?

SYNH stock was acquired by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC, Premier Asset Management LLC, Principal Financial Group Inc., UBS Group AG, Natixis Advisors L.P., State Board of Administration of Florida Retirement System, Envestnet Asset Management Inc., and Scotia Capital Inc.. Company insiders that have bought Syneos Health stock in the last two years include Jason M Meggs, John M Dineen, Jonathan Olefson, and Paul Colvin.
View insider buying and selling activity for Syneos Health
.

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $62.51.

How big of a company is Syneos Health?

Syneos Health has a market capitalization of $6.52 billion and generates $4.68 billion in revenue each year. The company earns $131.26 million in net income (profit) each year or $2.83 on an earnings per share basis. Syneos Health employs 24,000 workers across the globe.

What is Syneos Health's official website?

The official website for Syneos Health is www.syneoshealth.com.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at 919-876-9300 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.